NEW YORK (Reuters Health) -- Patients with hypercholesterolemia who do not reach target lipid levels with rosuvastatin have a better change of reaching their goals by adding ezetimibe as opposed to doubling the statin dose, a new study indicates.
For more information, please visit: http://www.thedoctorschannel.com/video/4423.html
Link to this comment:
All Comments (0)